These insights collectively demonstrate β-elemene’s role in thwarting late-stage autophagy and highlight lncRNA H19 as a pivotal target for reversing gefitinib resistance in lung cancer, with its inhibition potentiating the therapeutic efficacy of β-elemene. Here, H19 is linked to lung carcinoma.